api paracetamol10+ factories verified

MUXIANG GROUP is a high-tech group enterprise integrating the Research and Development, Production and Sales of Animal Health Products. It was founded in 1995 with a registered capital of 16 million Dollars, and the group has more than 600 employees.

Henan Chuangxin Biological Technology Co., Ltd. is a high-tech large-scale joint-stock enterprise integrating animal drug research and development, production, sales, and after-sales service. The company's Initial registered capital is 10.1 million yuan. In December 2012, the one-time with high score passed the acceptance of eight veterinary drug GMP production lines of the Ministry of Agriculture of the State. The production dosage forms involved powder, extraction of Chinese traditional medicine, large and small volume injections, disinfectants, feed additives and so forth. All workshops have achieved complete Automated manufacturing. Known as the GMP standard model factory of veterinary drugs in Henan Province. The company has several departments including Chuangxin Poultry Medicine Department, Xinbang Huifa Swine Medicine Department, Chuangxin Aquatic Products Department, Raw Material Department, and Overseas Development Department.

Jinan Andechem Company Limited., is a collection of research and development, production, sales and service in one of the chemical products company. The company is located in "quancheng" jinan. Jinan is a national historical and cultural city, one of the first batch of China's outstanding tourist cities, one of the birthplace of prehistoric culture longshan culture.

Our company offers variety of products which can meet your multifarious demands. We adhere to the management principles of "quality first, customer first and credit-based" since the establishment of the company and always do our best to satisfy potential needs of our customers. Our company is sincerely willing to cooperate with enterprises from all over the world in order to realize a win-win situation since the trend of economic globalization has developed with anirresistible force.

Hebei Guangren Pharmaceutical Technology Co., Ltd. is specializing in the manufacture of more than 300 kinds of veterinary drugs, main formations are liquid injection, powder, premix, oral liquid, suspension, granules, tablets, disinfectant and feed additives. It is now gradually becoming a production and sales base for traditional Chinese medicine extraction, veterinary drugs and feed additives.

Anhui BBCA Group, is mixed-ownership enterprises with state-owned shares, started from 1960's, which owns several manufacturing companies including BBCA Biochemical, BBCA Tiger Biotechnology, BBCA Food, BBCA Agriculture, BBCA Pharmaceutical, etc. Businesses overseas include factories in Thailand, Hungary, Brazil and sales companies in Belgium, France, the United States, and other countries.

Xi'an SASE Biotechnology Co., Ltd was established in 2014.

Hebei Veyong pharmaceutical Co., Ltd, was established in 2002, located in Shijiazhuang City, Hebei Province, China, next to the Capital Beijing. She is a large GMP-certified veterinary drug enterprise, with R&D, production and sales of veterinary APIs, preparations, premixed feeds and feed additives. As Provincial Technical Center, Veyong has established an innovated R&D system for new veterinary drug, and is the nationally known technological innovation-based veterinary enterprise. Veyong has two production bases: Shijiazhuang and Ordos, with 13 API products including Ivermectin, Eprinomectin, Tiamulin Fumarate, Oxytetracycline hydrochloride ects, and 12 preparation production lines including injection, oral solution, powder, premix, bolus, pesticides and disinfectant, ects. Veyong provides APIs, more than 100 own-label preparations, and OEM & ODM service.

Founded in 2019, our journey has been one of strategic evolution: From a regional pharmaceutical intermediate trader to a globally recognized partner for integrated cross-border supply and technical solutions. With over six years of concentrated expertise in the pharmaceutical and fine chemical sectors, we are dedicated to the mission of "Empowering Pharmaceutical Innovation. " By proactively navigating industry shifts and capitalizing on emerging opportunities, we have established a reputation for reliability and built solid, enduring partnerships across the globe.

Shanghai Likai Chemical Technology Co., Ltd. Was established in September 2020, headquartered in Songjiang District, Shanghai. With a registered capital of 5 million CNY, the company holds hazardous chemical operation licenses and import/export rights, focusing on fine chemicals, new energy materials, and pharmaceutical intermediates.